- AustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
Two-Year Suspension of Medical Device Tax Wins Industry Appreciation
AdvaMed chairman Vincent Forlenza, chairman, president and CEO of Becton Dickinson & Co. stated that “we are extremely appreciative of the bipartisan efforts to include a two-year suspension of the medical device tax in the tax extenders legislation.”
AdvaMed chairman Vincent Forlenza, chairman, president and CEO of Becton Dickinson & Co. stated that “we are extremely appreciative of the bipartisan efforts to include a two-year suspension of the medical device tax in the tax extenders legislation.”
According to an article on the Waltonian:
A spending and tax package hammered out in Congress would halt a tax on medical device manufacturers, giving a big win to Republicans and companies who have pushed for undoing the levy.
The Advanced Medical Technology Association (AdvaMed), the Medical Imaging & Technology Alliance (MITA) and the Medical Device Manufacturers Association (MDMA) today commended Congress for including suspension of the medical device excise tax in year-end legislation and urged its swift passage. Political consultants believe there is now an 80% likelihood that the tax extender legislation passes both the House of Representatives and the Senate. The tax, which took effect in 2013, helps fund the Affordable Care Act.
The current legislation package has a January 1, 2016 deadline for renewing various expiring tax credits. A report from the nonpartisan Congressional Research Service, however, concluded that the tax is most likely to affect consumer prices, not company profits.
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.